drugset / Trial / NCT01370330
131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
Summary
This is a compassionate use protocol to allow patients with advanced neuroblastoma palliative access to 131I-metaiodobenzylguanidine (131I-MIBG).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metaiodobenzylguanidine | Diagnostic / imaging agent | — | Intravenous |